Immediate Impact
1 by Nobel laureates 1 from Science/Nature 70 standout
Citing Papers
Ischemia-reperfusion injury: molecular mechanisms and therapeutic targets
2024 Standout
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Works of Thomas Olin being referenced
Targeting the Receptor Tyrosine Kinase ROR1 by Small Molecules
2021
A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Thomas Olin | 111 | 57 | 84 | 81 | 28 | 300 | |
| Yongli Lou | 129 | 33 | 59 | 97 | 14 | 357 | |
| Tatsuhiro Sakamoto | 50 | 35 | 63 | 31 | 34 | 264 | |
| Olufemi D. Owolabi | 82 | 58 | 58 | 11 | 20 | 355 | |
| Shinya Yuge | 188 | 50 | 44 | 23 | 15 | 364 | |
| C. W. Reifel | 80 | 106 | 106 | 37 | 28 | 358 | |
| Ken Shimizu | 148 | 113 | 125 | 63 | 19 | 363 | |
| Yoshihiko Igarashi | 120 | 11 | 25 | 64 | 16 | 321 | |
| G Kelényi | 53 | 117 | 32 | 11 | 41 | 329 | |
| Lihong Guan | 190 | 34 | 56 | 9 | 30 | 358 | |
| Masashi Kusakabe | 98 | 14 | 20 | 18 | 35 | 347 |
All Works
Loading papers...